The Valley Desk

NCT01014052 · Interventional trial

Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations

Overall registry status Completed

Phase 1

Conditions LCA (Leber Congenital Amaurosis), RP (Retinitis Pigmentosa)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov